HERON THERAPEUTICS, INC. /DE/ Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures
HERON THERAPEUTICS, INC. /DE/ (HRTX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures of 7.52 million shares for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-10.
Discontinued › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod · last filed 2013-05-10
- HERON THERAPEUTICS, INC. /DE/ share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2013-03-31 was 7.52M shares.
- HERON THERAPEUTICS, INC. /DE/ share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2012-12-31 was 18.54M shares.
- HERON THERAPEUTICS, INC. /DE/ share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2012-09-30 was 4.30M shares.
- HERON THERAPEUTICS, INC. /DE/ share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2012 was 37.48M shares, a 22.02% decline from fiscal 2011.
- HERON THERAPEUTICS, INC. /DE/ share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2011 was 48.07M shares, a 4319.42% increase from fiscal 2010.
- HERON THERAPEUTICS, INC. /DE/ share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2010 was 1.09M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 12 month |
|---|---|---|---|---|
| 2013-03-31 | 7.52M shares 10-Q · filed 2013-05-10 | 26.05M shares derived: sum of 2 quarters · filed 2013-05-10 | 30.35M shares derived: sum of 3 quarters · filed 2013-05-10 | |
| 2012-12-31 | 18.54M shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | 22.84M shares derived: sum of 2 quarters · filed 2013-03-01 | 37.48M shares 10-K · filed 2013-03-01 | |
| 2012-09-30 | 4.30M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-05 | 18.95M shares 10-Q · filed 2012-11-05 | ||
| 2012-06-30 | 14.65M shares 10-Q · filed 2012-08-09 | |||
| 2011-12-31 | 48.07M shares 10-K · filed 2013-03-01 | |||
| 2010-12-31 | 1.09M shares 10-K · filed 2013-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |